Jurisprudence - Lecture 2 - Notes
Informed Consent: Core Principles
Informed consent means patients have the right to control their bodies and health care; practitioners do not have the right to assess or treat a patient without the patient’s consent.
Consent must be specific to the procedure or treatment; a blanket or broad consent covering everything will not stand in court.
Written consent is important, especially for the initial intake and for explicit treatments or sensitive areas; verbal follow-ups are acceptable but should be documented.
Implied consent exists in practice (e.g., patient shows up for an appointment and participates), but it should be supported by clear verbal confirmation and documented evidence. Always verify patient understanding.
It is possible for a patient to withdraw consent at any time during treatment; you must stop the treatment and discuss alternatives or other options.
Misrepresentation or over-promising outcomes (e.g., claims of cures) is unethical and potentially unlawful; communicate evidence-based possibilities only.
Informed consent is not only about risks and benefits; it includes the nature of the procedure, who is performing it, alternatives, and consequences of not proceeding.
The process is dynamic and ongoing across visits; you should reiterate consent with any significant change in treatment or new risks.
Documentation should reflect both subjective (patient-reported) and objective (clinical findings) information that informs the consent.
Consent applies to communication about the patient with others (e.g., substitute decision makers) and to the patient’s health information privacy.
Laws and professional norms distinguish governance (being governed by a college/health ministry) from being controlled by the government in daily practice; practitioners are ultimately responsible for appropriate consent.
The Consent Process: Stages and Practical Steps
Stage 1: Pre-visit intake (online forms or in-person) to gather personal and health information; include confidentiality statements and cancellation policies.
Stage 2: Initial consult and intake; discuss what information will be collected and how it will be used; obtain consent to collect personal and health information before delving into health issues.
Stage 3: Pre-treatment consent; during the consult, explain the proposed treatment (e.g., acupuncture), risks, potential side effects, and alternatives; confirm understanding and obtain consent to proceed with the treatment.
Stage 4: Treatment consent during the visit; for each treatment, obtain consent specific to that procedure (e.g., needling, electroacupuncture, cupping, moxa, etc.); document verbal confirmation in the chart if written consent is not feasible that visit.
Stage 5: Consent for sensitive areas; for treatments involving sensitive regions (e.g., chest, abdomen, breasts, groin, upper inner thigh, buttocks), use separate written consent and clearly explain why these areas are targeted and the risks involved.
Stage 6: Post-treatment and follow-up consent; with each follow-up, verify there are no new risks or changes; document verbal consent and any changes in the treatment plan.
Stage 7: Consent to communicate with substitutes; obtain consent to share information with substitute decision makers when applicable; ensure there is documentation of who is authorized to make decisions for the patient.
Written vs Verbal vs Implied Consent
Written consent (initial and for specific procedures) provides clear evidence of what was explained and agreed to; includes the nature of the procedure, risks, alternatives, and consequences of not performing the procedure.
Verbal consent can be used for follow-up visits or when adding a new procedure; it should be documented in the chart with details of what was explained and what was agreed to.
Implied consent occurs when a patient’s actions imply agreement (e.g., continuing with a treatment after being informed); however, best practice is to obtain explicit consent, especially for higher-risk procedures or sensitive areas.
Blanket vs Procedure-Specific Consent
Do not use a blanket consent form that covers every possible procedure; consent must be specific to each treatment step and to each procedure (e.g., needles vs electroacupuncture vs cupping).
If a new procedure is added (e.g., switching from acupuncture to electroacupuncture), obtain a new written consent for that specific procedure.
For sensitive areas, obtain a separate written consent that clearly outlines the location, technique, benefits, risks, and why the area is being addressed.
Initial Intake vs Treatment Consent: The Documentation Flow
Initial intake consent covers the collection of personal information, contact details, demographic information, and basic health information; it establishes permission to gather data and use it for clinical care and billing, with notices about confidentiality. Example: Consent to collect, use, and disclose personal health information (PHI).
Treatment consent is procedure-specific and occurs after the initial intake; it covers the actual treatment (e.g., acupuncture with needles, cupping, moxa, etc.), potential risks, alternatives, and consequences of not proceeding.
When using electronic systems (e.g., Jane app), electronic signatures are acceptable for the initial intake; subsequent treatment-specific consent can be verbal with a chart note or a separate written form.
If a practitioner is licensed in multiple modalities (e.g., naturopathic and acupuncture), consider separate consents for each professional hat if required by the college; this avoids confusion about scope and liability.
Consent Contents: Core Components (for each consent form)
The nature of the assessment or treatment: what will be done, what it involves, and what the patient should expect.
Who is performing it: the practitioner's name and professional designation.
The reasons for the procedure: rationale and expected goals.
Material risks and side effects: what could realistically happen, including rare but serious risks.
Alternatives: other options, including non-treatment and referral to other professionals when appropriate.
Consequences of not having the procedure: what may occur if treatment is declined or delayed.
Questions and understanding: opportunity for questions and confirmation that the patient understands.
Specifics about sensory experiences: depth, sensation, and any potential discomfort during the procedure; patient preferences (e.g., “you want me to tell you when it will hurt” or “you’d rather I distract you”).
Clinician’s duty to educate: explain findings (e.g., tongue/pulse) and how they relate to symptoms; involve patient in learning about their health care.
Documentation of capacity: verify patient understanding, assess capacity if there are concerns, and document the decision-making process.
Risks and Side Effects: Examples and Context
Acupuncture risks: puncturing the lung (pneumothorax) is a potential but very small risk, especially with needles near the chest/back; emphasis on lay terms to avoid unnecessary fear while ensuring awareness.
Chest and back points: higher-risk areas; explain risk and signs to watch for post-treatment.
Bruising from cupping: not dangerous but visible; advise on timing if the patient has an event the next day.
Bleeding from needle insertion: generally minor; discuss any known bleeding tendencies or medications that affect bleeding.
Facial acupuncture: potential for minor bleeding; discuss likelihood and healing expectations.
Electroacupuncture: specific contraindications (e.g., pacemakers, implants, epilepsy); ensure patient is aware of risks and clarifications.
Sensitive areas: points around upper inner thigh, buttocks, chest wall, breast area; always obtain explicit consent for these areas and explain rationale and risks.
Risks vs benefits: not all treatments have the same risk profile; tailor the discussion to the patient’s condition and comorbidities; always present in plain language.
Layered risk communication: separate risks by modality (e.g., moxa, cupping) and scenario (home event, upcoming wedding, etc.).
Alternatives and Consequences of Not Treating
Alternatives to acupuncture or other therapies include acupressure, cupping, moxibustion, herbal medicine, or watchful waiting.
Referral to other health professionals when necessary (e.g., gastroenterologist, MRI for shoulder issues, GP for blood work).
If there is evidence suggesting a more serious underlying condition, advise the patient to seek medical evaluation; you may write a referral letter to the patient’s family doctor.
Even when not recommended, provide the patient with reasonable options and ensure they understand potential consequences of not proceeding.
Special Areas: Consent for Sensitive Areas
Sensitive areas require explicit consent and separate documentation (e.g., chest and breast areas, abdomen near reproductive organs, groin, buttocks).
Clarify that no point will be used in a sensitive area without patient consent; discuss alternatives that achieve the same therapeutic goal when possible.
When addressing sensitive points (e.g., REN 1, DU channels), explain the rationale and ensure patient comfort and autonomy; respect refusals and adjust the treatment plan accordingly.
Language and clarity matter: avoid ambiguous phrases; give concrete examples of what you plan to do and why.
Capacity and Substitute Decision Makers: Key Concepts
Capacity assessment: assume capacity unless there is evidence to the contrary; if the patient cannot understand or appreciate consequences, you should pause treatment and reassess, possibly referring to their physician.
Do not treat without appropriate consent; if capacity is in doubt, involve substitute decision makers and document who can decide on behalf of the patient.
Substitute decision maker hierarchy (Ontario context):
1) power of attorney for personal care (POA-PC)
2) spouse or partner (including common-law, same-sex, or living with them as a partner)
3) a child of the patient
4) a parent of the patient who does not have custody
5) a sibling
6) other relatives
7) public guardian or trustee
Court involvement: guardianship or appointment by the Consent and Capacity Board can determine who may substitute decision-maker in complex cases.
Documentation: collect substitute decision-maker information and ensure signatures are on file; do not rely on informal understandings alone.
Capacity in vulnerable situations: cases involving dementia, stroke, or other conditions require careful assessment, safe treatment planning, and possibly involvement of a social worker or health-care team allied professionals.
Language Barriers and Translation
Use translators when necessary; family members may translate, but you should obtain consent to share information with them and ensure translations are accurate.
Forms should be available in English and French; for other languages, consider bilingual copies or certified translation; ensure patient signs both language versions if needed.
Templates and College Resources
The college website provides consent templates and standard forms:
Consent to collect, use, and disclose personal health information (PHI)
Consent to treatment (for acupuncture, with or without needles, and for sensitive areas)
Consent forms for sensitive areas
Templates for intake forms, patient information forms, and treatment-specific consents
You can customize templates for your practice; ensure they reflect your clinical workflow and jurisdictional requirements.
Templates can help standardize the process and reduce risk of missing critical components, but you should tailor them to each patient and each procedure.
Addressing Misrepresentation, Fair Communication, and Ethics
Do not claim cures or guaranteed outcomes; communicate the evidence base and potential outcomes honestly.
Provide clear, factual information about risks, benefits, alternatives, and the consequences of not undergoing treatment.
Avoid pressuring patients; encourage questions and allow time to review information.
If a patient asks about a treatment outside your scope or competency (e.g., high-dose herbal regimens or unproven supplements), refer them to a qualified provider and document the referral and rationale.
When discussing supplements, understand your competency and potential interactions with medications; refer to a physician or nutrition expert as needed.
Document all communications and decisions; maintain a clear record of what was explained, understood, and agreed to by the patient.
Practical Scenarios, Questions, and Takeaways
Vitamin A megadoses example: if a practitioner recommends megadoses of vitamin A and claims dramatic cognitive improvement without detailing dosage, duration, risks, and alternatives, this constitutes misrepresentation and lack of essential consent components. Key missing elements include:
Specific nature of the recommendation and how it will be used (dosage, duration, administration)
Clear discussion of risks and potential liver damage with high-dose vitamin A
Viable alternatives (e.g., vitamin D, dietary changes, protein intake, exercise)
The importance of dosage, duration, timing, and monitoring when recommending supplements or herbs; avoid making absolute claims about efficacy without evidence.
Capacity and substitute decision makers in practice: the need to verify who can consent on behalf of an incapacitated patient, and to document who should be contacted if the primary decision maker is unavailable.
For cases involving language barriers or special populations, ensure translation support and culturally appropriate consent processes; keep documentation in the appropriate language with English/French copies if required.
In clinical practice, consider a staged approach to consent: initial intake consent to collect information; subsequent procedure-specific consents; separate consent for sensitive areas; and ongoing confirmation at follow-up visits.
Quick Reference: Practical Checklists
Before any treatment: verify patient’s capacity; obtain written consent for the initial intake (PHI collection) and a separate consent for the treatment.
For each procedure: document the nature, steps, involved practitioner, risks, alternatives, and consequences of not proceeding; obtain explicit consent.
For sensitive areas: secure separate written consent with explicit acknowledgement of the area and the risks.
Discuss alternatives and coordinate with other health professionals if needed; do not rely on a single modality when alternatives may be appropriate.
If capacity is questionable: pause treatment, involve substitute decision maker, or refer to the patient’s physician; document all steps.
After each treatment: confirm that consent remains valid; document verbal confirmation and any changes in plan.
Maintain language clarity: use lay terms; confirm patient understanding; allow questions.
Protect PHI: ensure consent to collect/use/disclose PHI is on file; specify who has access to the information.
Be prepared to justify ethical decisions to the regulatory college; keep thorough documentation and seek guidance when in doubt.
Bottom-Line Principles to Remember for Exams and Practice
Consent must be informed, voluntary, specific to each procedure, and well-documented.
Initial intake and subsequent treatment consents are distinct; separate consents are required for new procedures and sensitive areas.
Capacity matters: do not proceed without appropriate consent from a capable patient or a legally authorized substitute decision maker; document who can decide and how.
Always present risks, alternatives, and consequences of not proceeding; do not overstate benefits or promise cures.
Use plain language, teach-back style (ask patients to repeat back key points), and document the patient’s understanding and questions.
Know the college resources and templates for consent forms; customize to your practice while maintaining compliance.
Example Scenario Prompts for Study or Quiz Practice
Identify missing consent elements in a hypothetical scenario where a practitioner recommends a high-dose supplement with vague language and no dosage or duration.
Determine the highest-ranked substitute decision maker in a scenario where the POA-PC is unavailable, the spouse is not present, and a capable adult child is available.
Explain how you would handle consent for a treatment involving chest needles with a risk of pneumothorax, including how you would communicate the risk in lay terms and document consent.
Outline steps to obtain consent when language barriers require a translator and the patient’s PHI must remain confidential.
Describe how you would document follow-up verbal consent after adjusting a treatment plan based on patient feedback.